Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease (Hardback)Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease (author), Board on Health Care Services (author), Board on Health Sciences Policy (author), Food and Nutrition Board (author), Institute of Medicine (author), Christine M. Micheel (editor), John R. Ball (editor)
Hardback 334 Pages / Published: 25/06/2010
- Not available
Many people naturally assume that the claims made for foods and nutritional supplements have the same degree of scientific grounding as those for medication, but that is not always the case. The IOM recommends that the FDA adopt a consistent scientific framework for biomarker evaluation in order to achieve a rigorous and transparent process.
Publisher: National Academies Press
Number of pages: 334
Dimensions: 229 x 152 mm
You may also be interested in...
Thank you for your reservation
Your order is now being processed and we have sent a confirmation email to you at
When will my order be ready to collect?
Call us on or send us an email at
Unfortunately there has been a problem with your order
Please try again or alternatively you can contact your chosen shop on or send us an email at